An overview of cervical cancer epidemiology and prevention in the Baltic States

被引:12
作者
Kojalo, Una [1 ]
Tisler, Anna [2 ]
Parna, Kersti [2 ]
Kivite-Urtane, Anda [1 ]
Zodzika, Jana [1 ]
Stankunas, Mindaugas [3 ]
Baltzer, Nicholas [4 ]
Nygard, Mari [4 ]
Uuskula, Anneli [2 ]
机构
[1] Riga Stradins Univ, Inst Publ Hlth, Riga, Latvia
[2] Univ Tartu, Inst Family Med & Publ Hlth, Tartu, Estonia
[3] Lithuanian Univ Hlth Sci, Dept Hlth Management, Kaunas, Lithuania
[4] Canc Registry Norway, Oslo, Norway
关键词
Cervical cancer; Prevention; Human papillomavirus; HPV-VACCINATION; RISK-FACTORS; PREVALENCE; TRENDS; IMPLEMENTATION; INFECTION; LITHUANIA; MORTALITY;
D O I
10.1186/s12889-023-15524-y
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
AimsTo inform future Baltic States-specific policy analyses, we aimed to provide an overview of cervical cancer epidemiology and existing prevention efforts in Estonia, Latvia and Lithuania.MethodsA structured desk review: we compiled and summarized data on current prevention strategies, population demography and epidemiology (high risk human papillomavirus (HPV) prevalence and cervical cancer incidence and mortality over time) for each Baltic State by reviewing published literature and official guidelines, performing registry-based analyses using secondary data and having discussions with experts in each country.ResultsWe observed important similarities in the three Baltic States: high burden of the disease (high incidence and mortality of cervical cancer, changes in TNM (Classification of Malignant Tumors) stage distribution towards later stage at diagnosis), high burden of high-risk HPV in general population and suboptimal implementation of the preventive strategies as low screening and HPV vaccination coverage.ConclusionsCervical cancer remains a substantial health problem in the region and the efforts in addressing barriers by implementing a four-step plan for elimination cervical cancer in Europe should be made. This goal is achievable through evidence-based steps in four key areas: vaccination, screening, treatment, and public awareness.
引用
收藏
页数:9
相关论文
共 53 条
  • [1] Towards better implementation of cancer screening in Europe through improved monitoring and evaluation and greater engagement of cancer registries
    Anttila, Ahti
    Lonnberg, Stefan
    Ponti, Antonio
    Suonio, Eero
    Villain, Patricia
    Coebergh, Jan Willem
    von Karsa, Lawrence
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 (02) : 241 - 251
  • [2] Arbyn M., 2008, European guidelines for quality assurance in cervical cancer screening, Second Edition"
  • [3] Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis
    Arbyn, Marc
    Weiderpass, Elisabete
    Bruni, Laia
    de Sanjose, Silvia
    Saraiya, Mona
    Ferlay, Jacques
    Bray, Freddie
    [J]. LANCET GLOBAL HEALTH, 2020, 8 (02): : E191 - E203
  • [4] Bosch FX, 2013, VACCINE, V31, pF1, DOI [10.1016/j.vaccine.2013.07.026, 10.1016/j.vaccine.2013.10.001, 10.1016/j.vaccine.2013.10.003]
  • [5] Bray F., 2017, Cancer Incidence in Five Continents, VXI
  • [6] Bruni L., ICO IARC INFORM CTR
  • [7] Projected time to elimination of cervical cancer in the USA: a comparative modelling study
    Burger, Emily A.
    Smith, Megan A.
    Killen, James
    Sy, Stephen
    Simms, Kate T.
    Canfell, Karen
    Kim, Jane J.
    [J]. LANCET PUBLIC HEALTH, 2020, 5 (04) : E213 - E222
  • [8] Barriers, facilitators, and potential strategies for increasing HPV vaccination: A statewide assessment to inform action
    Cartmell, Kathleen B.
    Young-Pierce, Jennifer
    McGue, Shannon
    Alberg, Anthony J.
    Luque, John S.
    Zubizarreta, Maria
    Brandt, Heather M.
    [J]. PAPILLOMAVIRUS RESEARCH, 2018, 5 : 21 - 31
  • [9] Is a delay in the introduction of human papillomavirus-based cervical screening affordable?
    Castanon, Alejandra
    Rebolj, Matejka
    Sasieni, Peter
    [J]. JOURNAL OF MEDICAL SCREENING, 2019, 26 (01) : 44 - 49
  • [10] Central Statistical Bureau of Latvia, 2021, POP NUMB CHAR